Denali unveils $130M funding, series of deals

Denali Therapeutics Inc. (South San Francisco, Calif.) disclosed Thursday that it raised $130 million in a series B round and made five deals to flesh out its pipeline. The company is pursuing neurodegenerative diseases including Alzheimer's disease, Parkinson's disease

Read the full 399 word article

How to gain access

Continue reading with a
two-week free trial.